Form 8-K - Current report:
SEC Accession No. 0001171843-21-007914
Filing Date
2021-11-15
Accepted
2021-11-15 07:58:19
Documents
13
Period of Report
2021-11-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_111521.htm   iXBRL 8-K 26023
2 EXHIBIT 10.1 exh_101.htm EX-10.1 1522488
  Complete submission text file 0001171843-21-007914.txt   2024252

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE anik-20211112.xsd EX-101.SCH 3040
4 XBRL LABEL FILE anik-20211112_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE anik-20211112_pre.xml EX-101.PRE 22369
6 EXTRACTED XBRL INSTANCE DOCUMENT f8k_111521_htm.xml XML 3490
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 211406412
SIC: 3841 Surgical & Medical Instruments & Apparatus